James S. Scibetta, Chief Financial Officer at Pacira Pharmaceuticals, Inc. (PCRX), sold 10,000 shares at $28.05 ($281K) on 2013-06-28, disclosed to the SEC on 2013-07-02.
Scheduled sale ($280k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| PCRX | SELL | 2017-06-07 | $170K | — | Filing → |
| PCRX | SELL | 2017-05-17 | $1.0M | — | Filing → |
| PCRX | SELL | 2017-01-19 | $1.5M | — | Filing → |